Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series

Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series / Guerrieri, S.; Rubin, M.; Gattuso, I.; Zanetta, C.; Genchi, A.; Preziosa, P.; Rocca, M. A.; Filippi, M.; Moiola, L.. - In: JOURNAL OF NEUROLOGY. - ISSN 0340-5354. - 271:6(2024), pp. 3678-3681. [10.1007/s00415-024-12342-z]